LAG3 and neoplasm: As expected, not only did treatment with IL‐12 result in enhanced anti‐tumor response as seen by the suppression of tumor escape, it also resulted in the suppression of PD‐1 and LAG3 upregulation, providing further credentialing of the X‐mouse model.